SARS-CoV-2-assoziierte Todesfälle innerhalb des ersten Jahres der COVID-19-Pandemie: eine Autopsiestudie
暂无分享,去创建一个
M. Bauer | D. Wittschieber | N. Gassler | M. Hahnemann | Angelina Autsch | G. Mall | Hannah Ihle | Sandra Kleemann | Juliane Sanft | Michael Hubig | Mike Philipp | Michael Bauer | Stefanie Deinhardt-Emmer
[1] M. Monreal,et al. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study , 2022, Research and practice in thrombosis and haemostasis.
[2] Jaime Martín-Martín,et al. Comorbidities and autopsy findings of COVID-19 deaths and their association with time to death: a systematic review and meta-analysis , 2022, Current medical research and opinion.
[3] K. Zatloukal,et al. Host and microbiome features of secondary infections in lethal covid-19 , 2022, iScience.
[4] H. Moch,et al. Long-Term Persisting SARS-CoV-2 RNA and Pathological Findings: Lessons Learnt From a Series of 35 COVID-19 Autopsies , 2022, Frontiers in Medicine.
[5] I. Kern,et al. COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic , 2022, Diagnostics.
[6] A. van Rossum,et al. Cardiac inflammation and microvascular procoagulant changes are decreased in second wave compared to first wave deceased COVID-19 patients , 2021, International Journal of Cardiology.
[7] A. Zoufaly,et al. Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study , 2021, Cardiovascular research.
[8] M. Aepfelbacher,et al. Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases , 2021, Scientific Reports.
[9] F. Scholkmann,et al. Autopsy-Based Pulmonary and Vascular Pathology: Pulmonary Endotheliitis and Multi-Organ Involvement in COVID-19 Associated Deaths , 2021, Respiration.
[10] T. Glasz,et al. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases , 2021, GeroScience.
[11] O. Wichmann,et al. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence , 2021, BMC Medicine.
[12] W. Haas,et al. Die verschiedenen Phasen der COVID-19-Pandemie in Deutschland: Eine deskriptive Analyse von Januar 2020 bis Februar 2021 , 2021, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[13] S. Madhi,et al. Clinical characteristics and histopathology of COVID-19 related deaths in South African adults , 2021, PloS one.
[14] F. Heppner,et al. Causes of death and comorbidities in hospitalized patients with COVID-19 , 2021, Scientific Reports.
[15] A. Esmaeilzadeh,et al. COVID‐19: Virology, biology and novel laboratory diagnosis , 2020, The journal of gene medicine.
[16] C. Radu,et al. Post-Mortem Diagnosis and Autopsy Findings in SARS-CoV-2 Infection: Forensic Case Series , 2020, Diagnostics.
[17] Mathias W Pletz,et al. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2 , 2020, Histopathology.
[18] G. Ippolito,et al. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities , 2020, The Journal of infectious diseases.
[19] J. Sperhake. Autopsies of COVID-19 deceased? Absolutely! , 2020, Legal Medicine.
[20] L. Moore,et al. COVID-19 autopsy in people who died in community settings: the first series , 2020, Journal of Clinical Pathology.
[21] M. Aepfelbacher,et al. Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany , 2020, International Journal of Legal Medicine.
[22] R. Claus,et al. Postmortem Examination of Patients With COVID-19. , 2020, JAMA.
[23] K. Mertz,et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.
[24] H. Neuhauser,et al. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11 , 2014, Journal of Human Hypertension.
[25] H. Büller,et al. Prevention of Deep Vein Thrombosis after Hip Replacement , 1999, Thrombosis and Haemostasis.